Elda Tagliabue
0000-0001-9877-2903
Istituto Nazionale dei Tumori
222 papers found
Refreshing results…
Shedding of the 67-kD laminin receptor by human cancer cells.
Re: Killing of laminin receptor-positive human lung cancers by tumor-infiltrating lymphocytes bearing gamma delta + T-cell receptors.
Prognostic significance of laminin production in relation with its receptor expression in human breast carcinomas
Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl)retinamide
Colocalization of the p185HER2 oncoprotein and integrin α6β4 in Calu-3 lung carcinoma cells
Immunodetection of bone marrow micrometastases in breast carcinoma patients and its correlation with primary tumour prognostic features.
Relevance of Antibody Valency in EGF Receptor Modulation
Antibody-induced activation of p185HER2 in the human lung adenocarcinoma cell line Calu-3 requires bivalency
Overexpression of p185 is not related to erbB2 amplification in ovarian cancer
Prognostic Significance of the 67-Kilodalton Laminin Receptor Expression in Human Breast Carcinomas
Alteration of Laminin Production in Small-Cell Lung Carcinoma: Possible Correlation with the Absence of the Basement Membrane
Genetic changes in lung cancer
Characterization of two monoclonal antibodies directed against the 67 kDa high affinity laminin receptor and application for the study of breast carcinoma progression
p185 HER2/neu Epitope Mapping with Murine Monoclonal Antibodies
Production and Characterization of two Monoclonal Antibodies Directed against the Integrin β1 Chain
Study of a soluble tumor-associated marker composed of CEA related molecules recognized by three monoclonal antibodies
Selection of monoclonal antibodies which induce internalization and phosphorylation of P185HER2 and growth inhibition of cells with HER2/neu gene amplification
Laminin receptors on SCLC cells.
Characterization of a monoclonal antibody directed against the epidermal growth factor receptor binding site
Production of Monoclonal Antibodies against a New Carcinoma-associated Marker in View of Developing a Serological Test
Missing publications? Search for publications with a matching author name.